Publications
256
Citations
14,744
Est. group size
~30
Recurring co-author estimate
Active years
36
Publishing since 1991
James W. Rocco studies head and neck cancers, with a focus on how HPV (human papillomavirus) infection and genetic changes drive tumor development, progression, and treatment response. His work combines genomics, cell biology, and clinical outcomes research to better understand cancer evolution and improve diagnosis and treatment strategies, including for related cancers like anaplastic thyroid carcinoma. Prospective students would likely engage with both laboratory-based molecular cancer biology and translational/clinical research involving patient data.
Publication output has grown over the last decade, with a notable surge in 2023 followed by continued higher-than-earlier-years output through 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Building on ECOG-ACRIN E3311 to Strengthen Interpretation of Swallowing Outcomes
JCO oncology advances. · 2026
- Abstract 3617: Immunogenomic alterations driving premalignant lesions to invasive lesions of the head and neck
Cancer Research · 2026
- Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline Update
Archives of Pathology & Laboratory Medicine · 2025
- High-Risk HPV Testing in Head and Neck Carcinoma: Key Updates from the 2025 College of American Pathologists Guideline
Head and Neck Pathology · 2025
- 1398-P: Identifying Patients with Type 2 Diabetes Mellitus (T2DM) at Risk for Metabolic-Associated Steatotic Liver Disease (MASLD) in the Primary Care Setting
Diabetes · 2025
- Association of Systemic Inflammation Response Index with Outcomes for Head and Neck Cancer
International Journal of Radiation Oncology*Biology*Physics · 2025
- The genomic and evolutionary landscapes of anaplastic thyroid carcinoma
Cell Reports · 2024
- Cellular states are coupled to genomic and viral heterogeneity in HPV-related oropharyngeal carcinoma
Nature Genetics · 2023
- Inferring early genetic progression in cancers with unobtainable premalignant disease
Nature Cancer · 2023
- Y-27632 acts beyond ROCK inhibition to maintain epidermal stem-like cells in culture
Journal of Cell Science · 2023
- CDK4/6 and autophagy inhibitors synergize to suppress the growth of human head and neck squamous cell carcinomas
Molecular Carcinogenesis · 2023
- The genomic and evolutionary landscapes of anaplastic thyroid carcinoma
medRxiv · 2023
- Data from COOH-Terminal Binding Protein Regulates Expression of the p16<sup>INK4A</sup> Tumor Suppressor and Senescence in Primary Human Cells
2023
- Supplementary Figures 1-3 from COOH-Terminal Binding Protein Regulates Expression of the p16<sup>INK4A</sup> Tumor Suppressor and Senescence in Primary Human Cells
2023
- Supplementary Figures 1-3 from COOH-Terminal Binding Protein Regulates Expression of the p16<sup>INK4A</sup> Tumor Suppressor and Senescence in Primary Human Cells
2023
- International Journal of Radiation Oncology*Biology*Physics×24
- Oral Oncology×21
- Head & Neck×8
- Journal of Clinical Oncology×8
- Annals of Oncology×7
- Priyanka Bhateja
Medicine · The Ohio State University
- Marcelo Bonomi
Medicine · The Ohio State University
- Darrion Mitchell
Medicine · The Ohio State University
- Tyler Haddad
Medicine · The Ohio State University
- Lingbin Meng
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile